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The availability of hemolytically active cellular intermediates formed with compo- 
nents of the classical complement system has been critical to the determination of the 
order in which the components interact, their mechanism of interaction, and  their 
quantitation. Although it has been possible to achieve lysis of erythrocytes by the 
activation of properdin factors with certain complex polysaccharides (1,  2) or cobra 
venom factor (CoVF)  I (3), the formation of hemolytically  active cellular intermediates 
with properdin factors has not been previously accomplished. 
Activation of the terminal complement sequence  (C3-C9)  by CoVF involves the 
participation of two plasma proteins: properdin factor B  (4, 5), also termed C3 pro- 
activator (C3PA) (6), and glycine-rich beta glycoprotein (GBG) (7), a 100,000 tool wt 
pseudoglobulin; and factor D  (8), a  25,000  tool wt euglobulin, apparently identical 
with C3PA convertase (9)  and GBGase (10).  Initiation of fluid-phase reactions be- 
tween factors B  and D  may also be accomplished by the activated form of properdin 
factor A  (9, 11,  12), which is identical with the major cleavage product (C3b) of the 
third component of complement (C3). 
In the present study, cell-bound C3b was shown  to interact with factors B 
and D, generating a  cellular intermediate able to activate the terminal comple- 
ment sequence as assessed by its lysis in the presence of C3-C9. 
Materials and Methods 
Preparation of Plasma Proteins.--Factors  B and D were prepared from pooled fresh frozen 
citrated human plasma as described  (8). The factor B preparation yielded a single line on 
alkaline disk gel electrophoresis  and immunoelectrophoretic  analysis with goat antinormal 
human serum and was quantitated by radial immunodiffusion against monospecific antibody 
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(13). The factor D  preparation yielded no lines on alkaline disk gel electrophoresis,  having 
only 86 #g protein/ml by Folin assay (14), and had no factor B activity. The activated first 
component of guinea  pig complement  (Ci gp) and the human components  C4, C2, and C3 
were prepared and measured  as previously described (15-18). The C3 preparation contained 
830/zg C3/ml as assayed by radial immunodiffusion  (19), no immunochemically  detectable 
C5, and was free of factors B and D  activities. Human C5, C6, C7, C8, and C9 were pur- 
chased from Cordis Laboratories, Miami, Fla. 
Cellular Intermediates of the Classical Complement System.--Low ionic  strength Veronal- 
buffered saline with dextrose, pH 7.5, /z  =  0.075, containing 0.1% gelatin,  1.5  X  10  -4 M 
J+  Ca  , and 5  X  10  -4 M  Mg  ++  (DGVB ++)  (15, 20), and Veronal-buffered saline containing 
0.04 M ethylenediaminetetraacetate (GVB-EDTA)  were used as diluents. 
Sheep erythrocytes in the states EA, EAC1  (15), EAC4, and EAC14  (21) were prepared 
according to described methods. As indicated in the Results section, in one experiment EAC14 
generated by reacting EAC1 with purified C4, 100 U C4/108 EAC1 were used in the formation 
of EAC42. EAC42 were made by incubating EAC14  (108 cells/ml DGVB  ++) with an equal 
volume of C2 (1000 U/ml) for "Tma~, time" at 30°C, followed by immediate washing in ice- 
cold GVB-EDTA.  EAC43 were prepared by incubating EAC42,  108 cells/ml GVB-EDTA, 
with an equal volume of GVB-EDTA containing  8.3 #g C3/ml for 30 rain at 30°C, washing 
twice,  and allowing  the C2  to decay during a  subsequent  120-rain incubation at 37°C in 
GVB-EDTA. Guinea pig serum diluted 1:19 in GVB-EDTA (C-EDTA) was used as a source 
of C3-C9; in some experiments functionally pure human C3-C9 were used. 
RESULTS 
The Conversion of EAC43 by Factors  B  and D  to  an Active Intermediate  Ca- 
pable of Being L ysed by C  3-C  g.--Sheep E, EA, EAC4, and EAC43 wereincubated 
with factors B  and D,  and  C3-C9 in various combinations, and  the extent of 
hemolysis was determined (Table I). Only EAC43 were lysed, and this lysis was 
dependent on the presence of factors B and D. Although C3b was present on the 
cells, additional native C3 was required as an ingredient in the terminal com- 
plement mixture. 
The ability of EAC43  to produce intermediates that, after being exposed to 
factors B  and D, C3 and C5, and then washed, were capable of lysis by incuba- 
tion with the remaining terminal complement components was examined. Three 
reaction mixtures were prepared each containing 5  X  107 EAC43 and 0.8 ~g of 
factor D  in 1.5 ml of DGVB++: to the first was added 10 ~g of factor B; to the 
second, factor B  and 50 U  of C3; and to the third, factor B, C3, and 50 U  of C5. 
After incubation for 30 rain at 30°C,  the cells were washed twice with ice-cold 
DGVB ++ and resuspended in 2.5 ml of DGVB ++ containing 50 U  each of C3-C9, 
C5-C9,  and C6-C9,  respectively, for an additional 60-rain incubation at 37°C. 
100%  lysis occurred within each group  of cells, indicating that intermediates 
were  formed  at 30°C  that maintained the activities of the proteins to which 
they were exposed, factors B  and D,  C3  and  C5,  through two washes. In the 
absence of factor B hemolytically active intermediates were not formed. 
Quantitative  Effects  of Cell-Bound  C3b and Factor B in Formation of ttemolytic- 
ally Active Sites.--The quantitative relationship of cell-bound C3b and the num- 
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TABLE I 
Comersion of EAC43 by Factors B and D  to an Active Intermediate Capable of Being Lysed 
by C3-C9" 
Intermediate  Factor B  Factor D  C3-C9  Lysis (Z) 
E  +  +  +  0.01 
EA  +  +  +  0.01 
EAC4  -]-  +  +  0.02 
EAC43  -}-  +  +  1.98 
EAC43  --  +  +  0.03 
EAC43  +  --  +  0.01 
EAC43  +  +  C5-C9  0.02 
EAC43  +  +  C3, C6-C9  0.04 
* 0.5 >(  10 s cells, 0.3 #g of factor B, 0.4 #g of factor D, and 50 U each of C3, C5, C6, 
and C7 were incubated in 1.5 ml of DGVB  ++ for 30 rain at 30°C; 25 U of C8 and C9 were 
added; and incubation was continued for an additional 60 min at 37°C in a final volume of 
2.5 ml of DGVB  ++. After addition of 5 ml of saline, the extent of hemolysis was determined 
and the average number of effective hemolytic sites per cell was computed (Z). 
factors B  and D  and C3-9 is shown in Fig. 1. Batches of EAC14 prepared with 
purified C4 were converted to EAC42  and exposed to variable amounts of C3, 
ranging from none to 0.064 ~g/los EAC42,  and the C2 was allowed to decay. 
5  X  107 EAC43 from each batch were treated with 12 #g of factor B  and 0.86 
#g of factor D  in 1.0 ml of DGVB ++ for 30 rain at 30°C, followed by addition of 
1.5 ml of C-EDTA and further incubation for 60 rain at 37°C. A linear stoichio- 
metric  relationship between  the  amount  of  C3  used  to  prepare  the  EAC43 
intermediates and the generation of effective hemolytic sites was observed, with 
0.04 #g of C3 being sufficient for generation of one site per l0  s cells. Simulta- 
neously, a classical effective molecule titration of this C3 using 2000  U°xYC2hu/ 
l0  s EAC14  and 50 U  each of C3-C9/los EAC14 revealed that 0.16 #g was re- 
quired for generation of one site per los cells. 
The  quantitative  requirement  for  factor  B  was  examined  by  incubating 
5 X  l0  T EAC43, prepared as described in Materials and Methods, with 0.86 #g 
of factor D  and variable amounts of factor B in 1.0 ml of DGVB ++ for 30 rain at 
30°C,  followed by development with  1.5  ml of C-EDTA for 60 rain  at 37°C. 
Fig.  2  reveals  that  a  linear  relationship  was  obtained  between  the  average 
number of hemolytic sites per cell and the input of factor B, and that 0.17 gg 
were capable of producing one site per los EAC43. 
Kinetics  of Formation  and  Decay  of  the  Factor  B-Dependent  ttemolytically 
Active Site.--The generation and maintenance of the hemolytic activity formed 1308  ALTERNATE PATHWAY CELLULAR INTERMEDIATE 
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FIG. 1. C3b-dependent hemolytic sites per cell (Z) generated during formation of EAC43 
by addition of variable amounts of C3 to EAC42. 
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FIG. 2. Hemolytic sites per cell (Z) formed by addition of variable amounts of factor B 
to a mixture of EAC43 and factor D. 
by the interaction of EAC43 and factor D  with factor B  was examined in the 
experiments carried out at 30  ° and 37°C (Fig. 3). 5  ml of DGVB  ++ containing 
0.75 ug of factor B and prewarmed to 30  ° or 37°C were added to 5 ml of DGVB  ++ 
containing 5  X  108 EAC43 and 4.15 #g of factor D  also prewarmed to the corre- 
sponding temperature.  At varying times,  1.0-ml portions were  removed  and 
incubated with 1.5 ml of C-EDTA for 60 min at at 37°C. At both 30  ° and 37°C, DOUGLAS T.  FEARON,  K.  I~I~ANK AUSTEN~ SHAUN  RUDDY  1300 
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FIG. 3. Kinetics of generation of factor B-dependent hemolytic sites per cell  (Z)  at 30°C 
(O--Q) and 37°C  (O--O). 
generation of the hemolytically active enzyme began  without  detectable lag 
periods, consistent with first-order kinetics. Maximal activity at 30°C  was  ob- 
tailed after approximately 30 min, while peak activity at 37°C occurred  by 10min. 
The rate of decay of the factor B-dependent site on the washed intermediate 
was assessed at 30  ° and 37°C (Fig. 4). 8 X  108 EAC43 were incubated with 1.20 
pg of factor B and 6.64 pg of factor D in 16 ml of DGVB  ++ for 30 min at 30°C. 
The cells were washed twice in 20 ml of ice-cold DGVB  ++, resuspended in 16 
ml of DGVB  ++, and divided into two equal portions that were equilibrated at 
30  ° and 37°C, respectively. 1-ml samples were removed at varying times and 
developed with 1.5 ml of C-EDTA for 60 min at 37°C. Decay of the hemolyti- 
cally active site was more rapid at 37°C with a half-life of 15 min, while at 30°C 
the half-life was 50 min. In both instances, the kinetics of decay were consistent 
with a first-order reaction. 
DISCUSSION 
The demonstration that the fluid-phase interaction of C3b (activated factor 
A), C3Pase (factor D), and C3PA (properdin factor B) generated C3-cleaving 
activity (9)  suggested that C3b participated in the formation of an additional 
convertase distinct  from the  classical  C3  convertase. When  this  fluid-phase 
interaction was  studied for its capacity to bring the complement reaction to 
completion as appreciated by hemolysis, the efficiency was so limited that it was 
necessary to use erythrocytes from patients with paroxysmal nocturnal hemo- 
globinuria (1, 2)  that are uniquely susceptible to lysis by complement compo- 
nents. The present studies demonstrate that the factor B-dependent C3 con- 
vertase can be affixed to an erythrocyte by use of an intermediate bearing C3b, 
and that this convertase brings the hemolytic reaction to completion with ar~ 
efficiency comparable to that of classical convertase. 
The intermediate EAC43,  employed to initiate formation of the factor B- 1310  ALTERNATE  PATHWAY  CELLULAR  INTERMEDIATE 
dependent convertase, was devoid of C1 and C2 as indicated by its failure to 
lyse upon exposure to either °xYC2hu followed by  C-EDTA  (unpublished  ob- 
servations), or to C3-C9 alone (Table I). The absence of cell-bound C1 and C2 
resulted from interacting EAC142 with C3 in the presence of EDTA followed 
by washing and further incubation in EDTA for 2 h at 37°C. The evidence that 
the EAC43 intermediate was lysed by a new pathway included requirements 
for factors B and D  and cell-bound C3b. The quantity of C3b required for the 
EAC43 intermediate to be hemolytically active through the formation of the 
factor B-dependent convertase was similar to that observed in the formation of 
the classical enzyme, C423. The linear relationship between the availability of 
C3b and the extent of lysis when factors B  and D  and C3-C9 were present in 
excess clearly distinguishes this pathway from the reaction of classical C3 con- 
vertase with the terminal complement sequence (Fig. 1). 
The formation of the factor B-dependent convertase through the interaction 
of EAC43 and factor D with factor B began without a lag period and the number 
of active sites reached a peak (T  .....  ) earlier at 37°C than at 30°C (Fig. 3). The 
factor B-dependent site was stable to washing at 0°C, but exhibited first-order 
decay kinetics with a half-life of 15-20 rain at 37°C and 60 rain at 30°C (Fig. 4). 




o..o;  \  -,,,,,. 
o-°'  t  \  \ 
a06 [-  \  % 
0.02  -  57oc 
0.01  L  I  J  I  I  [  1  __ 
0  30  60  90  120  150  180 
MINUTES 
FIG.  4.  Kinetics  of  decay  of  factor  B-dependent  hemolytic sites per  cell  (Z)  at  30°C 
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(unpublished results). Although factor D  is essential for the formation of the 
factor B-dependent convertase and does not appear to decay, it is not yet possi- 
ble to distinguish whether its action is from the fluid phase or after binding to 
the intermediate. 
The factor B-dependent convertase can form subsequent intermediates with 
C3, and with C3 and C5, which tolerate washing at 0°C. The recognition of an 
intermediate that did not require  C5  for subsequent lysis revealed that the 
mechanism of attack by the terminal complement sequence induced by the 
factor B-dependent convertase is similar to that initiated by the classical  con- 
vertase in which C3 and C5 can be bound in the absence of C6 and C7. The 
previously described hemolytic reactions initiated by CoVF and complex poly- 
saccharides are also dependent on factors B and D  but appear to be mediated 
by the hemolytically inefficient reactive lysis mechanism, whereby C5 is bound 
to the cellular membrane as part of the nascent trimolecular complex, C567, 
performed in the fluid phase (22, 23). 
The linear stoichiometry of the effective molecule titration of C3b  (Fig. 1) 
and factor B  (Fig. 2)  and the first-order kinetics displayed by the generation 
(Fig. 3) and decay (Fig. 4) of the factor B-dependent hemolytic site are charac- 
teristics  consistent with the  "one-hit" theory as initially developed for the 
classical  complement system (24). There is also a remarkable similarity of the 
factor B-dependent convertase to the classical  C3 convertase: both are capable 
of activating the terminal complement sequence; both are formed during the 
interaction of three plasma proteins; both show a Tm~, time of optimal genera- 
tion of active sites as a consequence of temperature-dependent decay reactions; 
and after decay, each can be regenerated with the respective addition of factor 
B and C2. The functional analogy of factor B and C2 has been noted previously 
in studies of the role of factor B  in CoVF (25)  and zymosan-dependent (26) 
activation of the C3-cleaving enzyme. 
The use of hemolytically active cellular intermediates to examine the reac- 
tions occurring with C3b  and factors B  and D  has allowed extension of the 
one-hit theory to this molecular sequence, development of effective molecule 
titrations, recognition of the analogies to the functional characteristics of classi- 
cal C3  convertase, and discrimination of the probable mechanism of terminal 
complement activation from reactive lysis.  Furthermore,  these  studies have 
contributed to the appreciation of the potential role of this pathway for com- 
plement-mediated inflammation. Conceptually, it is possible for C3b produced 
by activation of  the  classical  complement system, the properdin  system, or 
some other enzymatic reaction to initiate intense utilization of the terminal 
components by formation of the factor B-dependent convertase. This view is 
consistent with the recent demonstration that lymphocyte tumor cells that had 
adsorbed trypsin-produced C3b were susceptible to factor B-dependent lysis 
(27). It is not clear whether the reported CoVF and lipopolysaccharide-induced 
activation of B  lymphocytes (28)  is through fixation of factor B-dependent 
convertase or the later fixation of C567 by reactive lysis. 1312  ALTERNATE  PATHWAY CELLIJ'LAR INTERMEDIATE 
SUM~-~RY 
The present studies demonstrate that the factor B-dependent C3 convertase 
can be affixed to an erythrocyte by use of an intermediate bearing C3b and that 
this convertase brings the hemolytic reaction to completion with an efficiency 
comparable to that of classical convertase. The evidence that the EAC43 inter- 
mediate was lysed by a new pathway includes requirements for factors B and D 
and cell-bound C3b for subsequent lysis by the terminal components, C3-C9. 
The linear stoichiometry of the effective molecule titrations of C3b and factor 
B,  and  the first-order kinetics displayed by the generation  and decay of the 
factor B-dependent hemolytic site are characteristics consistent with the one-hit 
theory as initially developed for the classical complement system. The use of 
hemolytically active cellular intermediates to examine the reactions occurring 
with C3b and factors B  and D  has allowed extension of the one-hit theory to 
this molecular sequence, development of effective molecule titrations, recogni- 
tion of the analogies to the functional characteristics of the classical C3 con- 
vertase, and discrimination of the probable mechanism of terminal complement 
activation from reactive lysis. 
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